Scarica l'app Stockscreener
3.57
4.39%
0.15
Pre-mercato:
3.58
0.01
+0.28%
Precedente Chiudi:
$3.42
Aprire:
$3.4
Volume 24 ore:
49,077
Relative Volume:
0.38
Capitalizzazione di mercato:
$6.85M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+8.84%
1M Prestazione:
+19.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.1501
$3.57
Intervallo di 1 settimana:
$3.1501
$3.57
Portata 52W:
$2.70
$8.86
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Confronta QNTM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
3.57 | 6.85M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Contrasting Quantum Biopharma (NASDAQ:QNTM) & ASLAN Pharmaceuticals (NASDAQ:ASLN) - Defense World
Quantum BioPharma Closes Third Tranche Offering with Amended Terms - TipRanks
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24 - WICZ
Quantum BioPharma Ltd - Stockhouse Publishing
Quantum BioPharma Advances Legal Actions Against Former CEO - TipRanks
Quantum BioPharma begins trading on Upstream a By Investing.com - Investing.com Nigeria
Quantum BioPharma Expands Global Reach with Upstream Listing - TipRanks
Quantum BioPharma begins trading on Upstream a - Investing.com
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM - Index-Journal
Quantum BioPharma Expands Global Reach with Upstream Exchange Dual Listing for 2025 - StockTitan
Quantum Biopharma approved to dual list on Upstream - MSN
Quantum BioPharma to Dual List on Upstream - TipRanks
Quantum BioPharma to list on Upstream trading platform - Investing.com
Quantum Biopharma Ltd. Approved to Dual List on Upstream - AccessWire
How This $4 Stock Is Taking On Wall Street's Big Banks With A $700 Million Lawsuit - Barchart
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency - Chronicle-Tribune
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares Latest Stock News & Market Updates - StockTitan
Quantum BioPharma Takes a Bold Step into Cryptocurrency! This Could Change Everything! - YaNoticias
Biopharmaceutical company Quantum BioPharma reveals it bought $1 million worth of cryptocurrency - PANews
Quantum BioPharma Secures $500K in Fresh Capital Through Second Tranche Offering - StockTitan
Quantum Biopharma Announces Closing of Second Tranche - AccessWire
Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing - crypto.news
Quantum BioPharma Invests $1 Million in Bitcoin - PortalCripto
Quantum BioPharma Acquires $1M of Bitcoin and Other Cryptos By Investing.com - Investing.com Australia
Quantum BioPharma Acquires $1M of Bitcoin and Other Cryptos - Investing.com India
Quantum BioPharma Makes Bold $1M Bitcoin Investment, Embraces Crypto for Future Transactions - StockTitan
Quantum BioPharma Diversifies Treasury with the Purchase of - GlobeNewswire
Quantum BioPharma Makes Bold $1M Strategic Investment in Bitcoin, Crypto Assets - StockTitan
QNTM stock touches 52-week low at $3.48 amid market fluctuations - Investing.com Canada
How This $4 Stock is Taking on Wall Street's Big Banks with a $700 Million Lawsuit - Asianet Newsable
Quantum BioPharma Ltd. and HUGE Biopharma Australia Pty Ltd Announces the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - Marketscreener.com
Quantum BioPharma Closes First Tranche of Debenture Offering, Raises CAD $500,000 in Fresh Capital - StockTitan
Quantum Biopharma Announces Closing of First Tranche - AccessWire
Quantum BioPharma progresses with drug trial dosing By Investing.com - Investing.com South Africa
Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma - The Eastern Progress Online
Quantum Biopharma Ltd (QNTM-Q) QuotePress Release - The Globe and Mail
Quantum BioPharma progresses with drug trial dosing - Investing.com
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - AccessWire
Quantum BioPharma Advances Phase 1 Trial After Positive Safety Review of Novel Drug Candidate - StockTitan
Quantum BioPharma announces convertible debenture offering By Investing.com - Investing.com Nigeria
Quantum BioPharma Launches $5 Million Private Placement - TipRanks
Quantum BioPharma announces convertible debenture offering - Investing.com
Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million - AccessWire
Quantum BioPharma Ltd. announced that it expects to receive CAD 5 million in funding - Marketscreener.com
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Allege - Galveston County Daily News
Quantum BioPharma Ltd expected to post a loss of $3.90 a shareEarnings Preview - XM
Quantum BioPharma initiates phase 1 multiple sclerosis trial By Investing.com - Investing.com Canada
Quantum BioPharma sues CIBC and RBC seeking $700M in damages - MSN
Quantum BioPharma initiates phase 1 multiple sclerosis trial - Investing.com
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - AccessWire
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Non sono disponibili dati finanziari per Quantum Biopharma Ltd (QNTM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):